MADRIGAL PHARMACEUTICALS, INC. (MDGL) Net Margin
- 2026-06-30: Net Margin -15.91%.
- 2026-03-31: Net Margin -30.32%.
- 2025-12-31: Net Margin -18.24%.
- 2025-09-30: Net Margin -39.75%.
Complete source-backed net margin history.
- Available history
- 2024-06-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -15.91% |
| 2026-03-31 | -30.32% |
| 2025-12-31 | -18.24% |
| 2025-09-30 | -39.75% |
| 2025-06-30 | -19.87% |
| 2025-03-31 | -53.36% |
| 2024-12-31 | -57.51% |
| 2024-09-30 | -172.04% |
| 2024-06-30 | -1038.20% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -30.08% |
| 2024-12-31 | -258.64% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |